| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Celularity Inc | Director | Class A Common Stock | 236K | $58.8K | $0.25 | Jun 14, 2023 | Direct |
| Celularity Inc | Director | Stock Option (Right to Buy) | 278K | Jun 14, 2023 | Direct | ||
| Kura Oncology, Inc. | Director | Option to purchase common stock | 26K | Jun 5, 2024 | Direct | ||
| SOLIGENIX, INC. | Director | Stock Option (Right to Buy) | 8.65K | Dec 12, 2024 | Direct | ||
| CTI BIOPHARMA CORP | Director | Stock Option (Right to Buy) | 0 | Jun 26, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SNGX | SOLIGENIX, INC. | Dec 12, 2024 | 1 | $0 | 4 | Dec 13, 2024 | Director |
| KURA | Kura Oncology, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| SNGX | SOLIGENIX, INC. | Dec 15, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Director |
| CTIC | CTI BIOPHARMA CORP | Jun 26, 2023 | 3 | $0 | 4 | Jun 26, 2023 | Director |
| CELU | Celularity Inc | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
| KURA | Kura Oncology, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| CTIC | CTI BIOPHARMA CORP | Apr 5, 2023 | 1 | $0 | 4 | Apr 7, 2023 | Director |
| SNGX | SOLIGENIX, INC. | Nov 17, 2022 | 1 | $0 | 4 | Nov 21, 2022 | Director |
| CELU | Celularity Inc | Jul 13, 2022 | 2 | $0 | 4 | Jul 15, 2022 | Director |
| KURA | Kura Oncology, Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 23, 2022 | Director |
| CELU | Celularity Inc | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| CELU | Celularity Inc | Jun 2, 2022 | 0 | $0 | 3 | Jun 3, 2022 | Director |
| CTIC | CTI BIOPHARMA CORP | Mar 9, 2022 | 1 | $0 | 4 | Mar 11, 2022 | Director |
| SNGX | SOLIGENIX, INC. | Sep 23, 2021 | 1 | $0 | 4 | Sep 24, 2021 | Director |
| CTIC | CTI BIOPHARMA CORP | Aug 24, 2021 | 0 | $0 | 3 | Sep 3, 2021 | Director |
| KURA | Kura Oncology, Inc. | Jun 22, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Director |